I-Isatuximab-irfc Injection

-Delile

• Ngaphambi kokuthola umjovo we-isatuximab-irfc,
• Umjovo we-Isatuximab-irfc ungadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:
• Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu, shayela udokotela wakho ngokushesha noma uthole ukwelashwa okuphuthumayo:

Umjovo we-Isatuximab-irfc usetshenziswa kanye ne-pomalidomide (Pomalyst) ne-dexamethasone ukwelapha i-myeloma eminingi (uhlobo lomdlavuza womnkantsha) kubantu abadala abathole okungenani eminye imishanguzo emibili, kufaka phakathi i-lenalidomide (Revlimid) kanye ne-proteasome inhibitor efana i-bortezomib (i-Velcade) noma i-carfilzomib (i-Kyprolis). Umjovo we-Isatuximab-irfc usesigabeni semithi ebizwa ngama-antibody monoclonal. Isebenza ngokusiza umzimba ukuthi unciphise noma umise ukukhula kwamangqamuzana omdlavuza.

Umjovo we-Isatuximab-irfc uza njengesisombululo (uketshezi) esizofakwa ngaphakathi (emthanjeni) ngudokotela noma unesi. Ekuqaleni, kuvame ukunikezwa ngezinsuku 1, 8, 15, no-22 zomjikelezo wokuqala wezinsuku ezingama-28. Ngemuva komjikelezo wokuqala, kuvame ukunikezwa ngezinsuku 1 no-15 zomjikelezo wezinsuku ezingama-28. Lo mjikelezo ungaphindaphindwa uma nje umuthi uqhubeka nokusebenza futhi ungabangeli imiphumela emibi kakhulu.

Udokotela noma umhlengikazi uzokubuka eduze ngenkathi uthola ukumuncwa nangemva kokufakwa ukuze aqiniseke ukuthi awuphenduli ngokungathi sína kulowo muthi. Uzonikezwa eminye imithi yokusiza ukuvimbela ukusabela ku-isatuximab-irfc. Tshela udokotela wakho noma umhlengikazi ngokushesha uma uhlangabezana nalezi zimpawu ezilandelayo ezingase zivele ngesikhathi sokumnika noma amahora angama-24 ngemuva kokuthola ukumnika: isicanucanu, ukuphefumula, ukukhwehlela noma ukubanda.

Udokotela wakho angamisa unomphela noma okwesikhashana ukwelashwa kwakho. Lokhu kuncike ekutheni umuthi usebenza kanjani kuwe kanye nemiphumela emibi oyitholayo. Qiniseka ukuthi utshela udokotela wakho ukuthi uzizwa kanjani ngesikhathi sokwelashwa kwakho nge-isatuximab-irfc.

Buza usokhemisi noma udokotela wakho ikhophi lemininingwane yomkhiqizi yesiguli.

Lo muthi ungabekelwa okunye ukusetshenziswa; buza udokotela wakho noma usokhemisi ukuthola eminye imininingwane.

Ngaphambi kokuthola umjovo we-isatuximab-irfc,

• Tshela udokotela wakho kanye nosokhemisi uma une-allergies ku-isatuximab-irfc, noma imiphi eminye imithi, noma iziphi izithako zomjovo we-isatuximab-irfc. Buza usokhemisi wakho ukuthola uhlu lwezithako.
• Tshela udokotela wakho kanye nosokhemisi ukuthi imiphi eminye imishanguzo kadokotela neyokungabhalisi, amavithamini, izithasiselo zokudla okunempilo, nemikhiqizo yamakhambi oyithathayo noma ohlela ukuyithatha. Udokotela wakho angadinga ukushintsha imithamo yemithi yakho noma akuqaphele ngokucophelela ngemiphumela emibi.
• utshele udokotela wakho uma unesifo.
• utshele udokotela wakho uma ukhulelwe noma uhlela ukukhulelwa. Kufanele usebenzise ukulawulwa kokubeletha ukuvimbela ukukhulelwa ngesikhathi sokwelashwa kwakho ngomjovo we-isatuximab-irfc nezinyanga ezi-5 ngemuva komthamo wakho wokugcina. Khuluma nodokotela wakho ngezindlela zokulawula ukubeletha ongazisebenzisa. Uma ukhulelwa ngenkathi uthola umjovo we-isatuximab-irfc, shayela udokotela wakho. Umjovo we-Isatuximab-irfc ungalimaza umbungu.
• tshela udokotela wakho uma uncelisa. Udokotela wakho angakutshela ukuthi ungancelisi ngesikhathi sokwelashwa kwakho nge-isatuximab-irfc.

Ngaphandle kokuthi udokotela wakho akutshele ngenye indlela, qhubeka nokudla okuvamile.

Uma uphuthelwa isikhathi sokuthola i-isatuximab-irfc, shayela udokotela wakho ngokushesha okukhulu.

Umjovo we-Isatuximab-irfc ungadala imiphumela emibi. Tshela udokotela wakho uma kukhona kulezi zimpawu ezinzima noma ezingapheli:

• isifo sohudo
• isicanucanu
• ukuhlanza

Eminye imiphumela emibi ingaba mibi. Uma uhlangabezana nenye yalezi zimpawu, shayela udokotela wakho ngokushesha noma uthole ukwelashwa okuphuthumayo:

• Ukugodola, umphimbo obuhlungu, umkhuhlane noma ukukhwehlela; ubuhlungu noma ukushisa lapho uchama; noma ezinye izimpawu zokutheleleka
• ukopha okungavamile, ukulimaza okulula, noma igazi elibomvu ezihlalweni
• ukuphefumula, isiyezi noma ubuthakathaka, noma isikhumba esiphaphathekile

I-Isatuximab-irfc ingakhuphula ubungozi bokuthola amanye amagciwane. Khuluma nodokotela wakho ngezingozi zokuthola lo muthi.

I-Isatuximab-irfc ingadala eminye imiphumela emibi. Shayela udokotela wakho uma unezinkinga ezingavamile ngenkathi uthola lo muthi.

Uma uthola imiphumela emibi kakhulu, wena noma udokotela wakho ungathumela umbiko kuhlelo lwe-Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting online (http://www.fda.gov/Safety/MedWatch) noma ngocingo ( 1-800-332-1088).

Uma kwenzeka ukweqisa ngokweqile, shayela ucingo losizo lokulawula ubuthi ku-1-800-222-1222. Imininingwane iyatholakala online ku-https: //www.poisonhelp.org/help. Uma isisulu siwile, saba nokuquleka, sinenkinga yokuphefumula, noma singakwazi ukuvuswa, shayela ngokushesha abezimo eziphuthumayo ku-911.

Gcina wonke ama-aphoyintimenti nodokotela wakho kanye nelabhorethri. Udokotela wakho angalawula izivivinyo ezithile zelebhu ukuze ahlole impendulo yomzimba wakho kumjovo we-isatuximab-irfc.

Ngaphambi kokwenza noma yiluphi uvivinyo lwelabhoratri, tshela udokotela wakho kanye nabasebenzi belebhuthi ukuthi uthola umjovo we-isatuximab-irfc.

Buza usokhemisi wakho noma imiphi imibuzo onayo mayelana nomjovo we-isatuximab-irfc.

Kubalulekile ukuthi ugcine uhlu olubhaliwe lwayo yonke imishanguzo oyisebenzisayo kadokotela kanye nokungabhaliswanga (ngaphezulu kokuthenga), kanye nanoma yimiphi imikhiqizo efana namavithamini, amaminerali, noma ezinye izithako zokudla. Kufanele uze nalolu hlu njalo uma uvakashela udokotela noma uma ungeniswa esibhedlela. Kubaluleke kakhulu futhi nemininingwane ebalulekile ukuthi uphathe uma kwenzeka kunezimo eziphuthumayo.

• USarclisa^®